ImmPACT Bio

About:

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

Website: http://www.immpact-bio.com/

Top Investors: OrbiMed, Foresite Capital, Takeda Ventures, Johnson & Johnson Innovation – JJDC, Novartis Venture Fund

Description:

ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.